Basit öğe kaydını göster

Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study

dc.contributor.authorLeblebicioglu, H.
dc.contributor.authorSunbul, M.
dc.contributor.authorGuner, R.
dc.contributor.authorBodur, H.
dc.contributor.authorBulut, C.
dc.contributor.authorDuygu, F.
dc.contributor.authorBeeching, N. J.
dc.date.accessioned2020-06-21T13:33:43Z
dc.date.available2020-06-21T13:33:43Z
dc.date.issued2016
dc.identifier.issn1198-743X
dc.identifier.issn1469-0691
dc.identifier.urihttps://doi.org/10.1016/j.cmi.2015.11.024
dc.identifier.urihttps://hdl.handle.net/20.500.12712/13405
dc.descriptionLeblebicioglu, Hakan/0000-0002-6033-8543; Fletcher, Tom/0000-0002-3712-415X; Beeching, Nicholas/0000-0002-7019-8791en_US
dc.descriptionWOS: 000375399900025en_US
dc.descriptionPubMed: 26806137en_US
dc.description.abstractHealthcare-related transmission of Crimean-Congo haemorrhagic fever (CCHF) is a well-recognized hazard. We report a multicentre retrospective cross-sectional study undertaken in Turkey in 2014 in nine hospitals, regional reference centres for CCHF, covering the years 2002 to 2014 inclusive. Data were systematically extracted from charts of all personnel with a reported health care injury/accident related to CCHF. Blood samples were tested for CCHF IgM/IgG by enzyme-linked immunosorbent assay and/or viral nucleic acid detection by PCR after the injury. Fifty-one healthcare-related exposures were identified. Twenty-five (49%) of 51 resulted in laboratory-confirmed infection, with a 16% (4/25) overall mortality. The main route of exposure was needlestick injury in 32/51 (62.7%). A potential benefit of post-exposure prophylaxis with ribavirin was identified. (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.en_US
dc.description.sponsorshipWellcome TrustWellcome Trust; UK Ministry of Defence; National Institute for Health Research Health Protection Research Unit (NIHRHPRU) in Emerging and Zoonotic Infectionsen_US
dc.description.sponsorshipFinancial support was received from Wellcome Trust and the UK Ministry of Defence (to TF) and the National Institute for Health Research Health Protection Research Unit (NIHRHPRU) in Emerging and Zoonotic Infections, a partnership between the University of Liverpool, Liverpool School of Tropical Medicine and Public Health England (PHE) (to NJB). The views expressed are those of the authors and not necessarily those of the Turkish Ministry of Health, the NHS, the NIHR, the Department of Health or Public Health England. All authors report no conflicts of interest relevant to this article.en_US
dc.language.isoengen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.isversionof10.1016/j.cmi.2015.11.024en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCrimean-Congo haemorrhagic feveren_US
dc.subjecthealthcare associateden_US
dc.subjectinfection prevention and controlen_US
dc.subjectribavirinen_US
dc.subjectviral haemorrhagic feveren_US
dc.titleHealthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional studyen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume22en_US
dc.identifier.issue4en_US
dc.relation.journalClinical Microbiology and Infectionen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster